Literature DB >> 14708673

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version).

Roberto de Franchis, Antoine Hadengue, George Lau, Daniel Lavanchy, Anna Lok, Neil McIntyre, Alfonso Mele, Gustav Paumgartner, Antonello Pietrangelo, Juan Rodés, William Rosenberg, Dominique Valla.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14708673

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  90 in total

1.  Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement.

Authors:  Anthony E Samir; Manish Dhyani; Abhinav Vij; Atul K Bhan; Elkan F Halpern; Jorge Méndez-Navarro; Kathleen E Corey; Raymond T Chung
Journal:  Radiology       Date:  2014-11-13       Impact factor: 11.105

2.  Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective.

Authors:  Helen Dakin; Morris Sherman; Scott Fung; Carrie Fidler; Anthony Bentley
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

3.  Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Authors:  Jorge Méndez-Navarro; Kathleen E Corey; Hui Zheng; Lydia L Barlow; Jae Young Jang; Wenyu Lin; Hong Zhao; Run-Xuan Shao; Steven L McAfee; Raymond T Chung
Journal:  Liver Int       Date:  2010-08-25       Impact factor: 5.828

Review 4.  Predicting survival in hepatitis B.

Authors:  M Sherman
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 5.  Peginterferon-alpha-2a (40kD): a review of its use in the management of patients with chronic hepatitis B.

Authors:  Gayle W Robins; Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Misperceptions among patients with chronic hepatitis B in Singapore.

Authors:  Chun-Tao Wai; Belinda Mak; Winnie Chua; Mei-Hua Tan; Seline Ng; Amelia Cheok; Mee-Lian Wong; Seng-Gee Lim
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 7.  Management of patients with HBeAg-negative chronic hepatitis B.

Authors:  Nripen Saikia; Rupjyoti Talukdar; Subhasish Mazumder; Sudeep Khanna; Rakesh Tandon
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

8.  The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.

Authors:  Stephanie D Chao; Ellen T Chang; Phuoc V Le; Wijan Prapong; Michaela Kiernan; Samuel K S So
Journal:  J Immigr Minor Health       Date:  2007-11-08

9.  Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Authors:  Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai V Naoumov
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

10.  Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B.

Authors:  Pham Thi Le Hoa; Nguyen Tien Huy; Le The Thu; Cao Ngoc Nga; Kazuhiko Nakao; Katsumi Eguchi; Nguyen Huu Chi; Bui Huu Hoang; Kenji Hirayama
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.